Collateral for a security interest recorded Oct 24, 2024 (Ascent Partners Fund LLC).
Term ends no later than Dec 10, 2029 · Medium confidence
20-year base term ends Oct 15, 2029
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Held by Reshape Lifesciences Inc.
Filed Jan 10, 2022 as application 17/572,387 · Granted Sep 17, 2024
Base term plus 56 days of patent term adjustment (USPTO delay)
Today
2009
2029
Clock starts
Oct 15, 2009
Oct 15, 2009
Ends no later than
Dec 10, 2029
Dec 10, 2029
Granted
Sep 17, 2024
Sep 17, 2024
base term
patent term adjustment
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
56
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
0 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 56 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 1 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 15, 2009, when application 12/580,132, the earliest non-provisional in its chain, was filed (this one was filed Jan 10, 2022) | Oct 15, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +56 days, USPTO patent term adjustment record | Dec 10, 2029 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Dec 10, 2029 | Medium confidence |
This family
| US 8,162,969 | In force Oct 2029 | Oct 2029 |
| US 7,854,745 | In force Oct 2029 | Oct 2029 |
| US 8,845,674 | In force Oct 2029 | Oct 2029 |
| US 9,539,132 | In force Oct 2029 | Oct 2029 |
| US 10,327,936 | In force Oct 2029 | Oct 2029 |
| US 11,219,543 | In force Mar 2030 | Mar 2030 |
| US 12,090,075 | this patent no later than Dec 2029 | no later than Dec 2029 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 9, 2024 Reel 68238, frame 300 | Brister, Mark C.; Quintana, Nelson; Patel, Kaushik A.; Drake, Neil R.; Lievares, Antonio C.; Markovic, Dubravka; Rasdal, Andrew P.; Vandenberg, Amy D.l. | Obalon Therapeutics, Inc. | Assignment of Assignor's Interest |
| Aug 9, 2024 Reel 68535, frame 965 | Obalon Therapeutics, Inc. | Reshape Lifesciences Inc. | Change of Name |
| Oct 24, 2024 Reel 70166, frame 882 | Reshape Lifesciences Inc. | Ascent Partners Fund LLC | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Dec 2029
Term ends no later than Dec 10, 2029. Maintenance fees still fall due before then
Note
A terminal disclaimer is on file and its reference is not resolved. No cap is applied and none is guessed
Note
The 56 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Open question
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Dec 10, 2029. We will not guess the cap.
Citations
2
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
This computed term ends no later than the date shown; an unresolved terminal disclaimer may end it earlier. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.